SOCIETY ON SARCOPENIA, CACHEXIA, & WASTING DISORDERS (SCWD)
Driving Innovation in Research,
Education and Clinical Excellence Worldwide
From Basic Science to Clinical Management of Sarcopenia, Cachexia and Wasting
Multidisciplinary Approaches to Improve Patients’ Outcomes
The Society on Sarcopenia, Cachexia, and Wasting Disorders (SCWD) focuses on muscle wasting across a number of medical conditions and strives to enhance global health by advancing cutting-edge research that informs effective policies and practices for medical professionals and healthcare stakeholders.
Our mission is to address the challenges of cachexia (including cancer cachexia), sarcopenia, and wasting disorders involving all stakeholders to improve the lives of patients with cachexia and sarcopenia worldwide.
Explore the latest programs and information about Sarcopenia, Cachexia, & Wasting Disorders
Stay Involved
SCIENCE & RESEARCH
Your Area of Expertise
Explore our Programs and Resources
- 🗓️ Date: 2025-08-01
- 📰 Journal: Journal Of Cachexia Sarcopenia And Muscle
- 🗓️ Date: 2025-08-01
- 📰 Journal: Journal Of Cachexia Sarcopenia And Muscle
- 🗓️ Date: 2025-08-01
- 📰 Journal: Journal Of Cachexia Sarcopenia And Muscle
- 🗓️ Date: 2025-08-01
- 📰 Journal: Journal Of Cachexia Sarcopenia And Muscle
- 🗓️ Date: 2025-07-07
- 📰 Journal: Metabolism-Clinical And Experimental
- 🗓️ Date: 2025-07-07
- 📰 Journal: Metabolism-Clinical And Experimental
- 🗓️ Date: 2025-07-05
- 📰 Journal: Biomedicine & Pharmacotherapy
- 🗓️ Date: 2025-07-04
- 📰 Journal: Journal Of Cardiac Failure
- 🗓️ Date: 2025-07-01
- 📰 Journal: Age And Ageing
Multiomics and cellular senescence profiling of aging human skeletal muscle uncovers Maraviroc as a senotherapeutic approach for sarcopenia.
Scutellarein attenuates cancer cachexia-induced muscle atrophy via targeted inhibition of the JAK/STAT pathway.
Aging induces sarcopenia by disrupting the crosstalk between the skeletal muscle microenvironment and myofibers.
Effects of two-year adapted physical exercise program and nutritional counselling on cardio-sarcopenia syndrome in older adults with low muscle function.
A serum creatinine-cystatin C-derived index as a predictive marker for sarcopenia incidence and progression in community-dwelling older adults: a prospective cohort study.
Our Dedication to Advancing Science
The Journal of Cachexia, Sarcopenia and Muscle is committed to pioneering research that addresses the critical challenges of cachexia and sarcopenia. By publishing the finest work from across the life sciences, we unite experts to push the boundaries of knowledge and improve patient care. Discover how our journal can support your research through opportunities for publication and collaboration.
Register Now!
Embrace this opportunity to redefine the field and create lasting impact in the lives of patients worldwide.